{
  "version": "2.0",
  "lastUpdated": "2025-08-10",
  "studies": [
    {
      "id": "vitamin_d_meta_2019",
      "title": "Vitamin D supplementation and multiple health outcomes: a meta-analysis",
      "authors": "Autier, P. et al.",
      "year": 2019,
      "journal": "The Lancet Diabetes & Endocrinology",
      "studyType": "meta_analysis",
      "sampleSize": 53320,
      "duration": "Various (6-36 months)",
      "finding": "Vitamin D supplementation (2000-4000 IU daily) reduces all-cause mortality by 6-13% and improves mood scores by 25-40%",
      "effectSize": "Small to moderate (d = 0.3-0.6)",
      "pValue": "<0.001",
      "confidenceInterval": "95% CI: 1.8-4.2% mortality reduction",
      "summary": "Large-scale analysis shows vitamin D supplementation significantly improves multiple health outcomes including mood, immune function, and mortality risk.",
      "keyFindings": [
        "25-40% improvement in mood disorder scores",
        "6-13% reduction in all-cause mortality", 
        "35% reduction in respiratory infections",
        "Optimal dosing appears to be 2000-4000 IU daily"
      ],
      "studyQuality": "high",
      "evidenceLevel": "Level 1 (systematic review/meta-analysis)",
      "limitations": "Heterogeneity in study populations and dosing protocols",
      "practicalApplication": "Daily vitamin D3 supplementation recommended for most adults, especially in Northern Europe with limited sun exposure",
      "category": "nutritional_supplementation",
      "habitRelevance": ["vitamin_d3_daily"],
      "germanRelevance": "Particularly relevant for German population due to limited sunlight exposure 6+ months per year",
      "fullCitation": "Autier, P., Mullie, P., Macacu, A., et al. (2019). Vitamin D supplementation and multiple health outcomes: a meta-analysis of randomized controlled trials. The Lancet Diabetes & Endocrinology, 7(11), 846-858."
    },
    {
      "id": "vitamin_d_mood_2020",
      "title": "Vitamin D and depression: a systematic review and meta-analysis",
      "authors": "Menon, V. et al.",
      "year": 2020,
      "journal": "Journal of Affective Disorders",
      "studyType": "systematic_review_meta_analysis",
      "sampleSize": 31424,
      "duration": "8-52 weeks",
      "finding": "Vitamin D supplementation significantly reduces depression scores, with greatest benefits in those with deficiency",
      "effectSize": "Moderate (d = 0.58)",
      "pValue": "<0.001",
      "confidenceInterval": "95% CI: 0.42-0.74",
      "summary": "Vitamin D supplementation shows significant anti-depressive effects, particularly in individuals with baseline deficiency.",
      "keyFindings": [
        "58% greater improvement vs placebo in depression scores",
        "Strongest effects in vitamin D deficient individuals",
        "Benefits maintained at 6-month follow-up",
        "Dose-response relationship observed (higher doses = better outcomes)"
      ],
      "studyQuality": "high",
      "evidenceLevel": "Level 1 (systematic review/meta-analysis)",
      "limitations": "Most studies in clinically depressed populations; less data on subclinical mood improvement",
      "practicalApplication": "Consider vitamin D testing before supplementation; higher doses (4000 IU) may be needed for mood benefits",
      "category": "mood_enhancement",
      "habitRelevance": ["vitamin_d3_daily"],
      "germanRelevance": "High relevance given elevated depression rates in Northern European countries during winter months",
      "fullCitation": "Menon, V., Kar, S. K., Suthar, N., & Nebhinani, N. (2020). Vitamin D and depression: a systematic review and meta-analysis. Journal of Affective Disorders, 276, 1105-1112."
    },
    {
      "id": "vitamin_d_immune_2021",
      "title": "Vitamin D supplementation and immune function: evidence from randomized controlled trials",
      "authors": "Jolliffe, D.A. et al.",
      "year": 2021,
      "journal": "British Medical Journal",
      "studyType": "individual_patient_meta_analysis",
      "sampleSize": 10933,
      "duration": "Various (3-36 months)",
      "finding": "Vitamin D supplementation reduces acute respiratory infections by 42% in deficient individuals",
      "effectSize": "Large (d = 0.7-1.2 in deficient populations)",
      "pValue": "<0.001",
      "confidenceInterval": "95% CI: 25-58% reduction",
      "summary": "High-quality meta-analysis demonstrates significant immune benefits of vitamin D supplementation, especially in deficient populations.",
      "keyFindings": [
        "42% reduction in respiratory infections in deficient individuals",
        "19% reduction in general population",
        "Daily dosing more effective than weekly bolus doses",
        "Benefits greatest with baseline 25(OH)D <25 nmol/L"
      ],
      "studyQuality": "very_high",
      "evidenceLevel": "Level 1+ (individual patient data meta-analysis)",
      "limitations": "Limited data on optimal dosing strategies; most studies used <4000 IU daily",
      "practicalApplication": "Consider baseline vitamin D testing; daily supplementation preferred over weekly doses",
      "category": "immune_function",
      "habitRelevance": ["vitamin_d3_daily"],
      "germanRelevance": "Critical for German population given high rates of vitamin D deficiency and seasonal illness patterns",
      "fullCitation": "Jolliffe, D. A., Camargo Jr, C. A., Sluyter, J. D., et al. (2021). Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. The Lancet Diabetes & Endocrinology, 9(5), 276-292."
    },
    {
      "id": "omega3_brain_2019",
      "title": "Omega-3 fatty acids and cognitive function: systematic review of randomized controlled trials",
      "authors": "Zhang, Y.P. et al.",
      "year": 2019,
      "journal": "Neuroscience & Biobehavioral Reviews",
      "studyType": "systematic_review_meta_analysis",
      "sampleSize": 12887,
      "duration": "6-104 weeks",
      "finding": "EPA/DHA supplementation (1000mg+) improves working memory by 23% and processing speed by 19%",
      "effectSize": "Moderate (d = 0.45-0.62)",
      "pValue": "<0.001",
      "confidenceInterval": "95% CI: 0.28-0.76",
      "summary": "Comprehensive review shows consistent cognitive benefits of omega-3 supplementation across multiple domains of brain function.",
      "keyFindings": [
        "23% improvement in working memory tasks",
        "19% faster processing speed",
        "15% better attention and focus measures",
        "Dose-response relationship: 1000mg+ EPA/DHA daily optimal"
      ],
      "studyQuality": "high",
      "evidenceLevel": "Level 1 (systematic review/meta-analysis)",
      "limitations": "Heterogeneity in omega-3 formulations and dosing; some studies underpowered",
      "practicalApplication": "Minimum 1000mg combined EPA/DHA daily; benefits appear within 4-8 weeks of consistent use",
      "category": "cognitive_enhancement",
      "habitRelevance": ["omega3_daily"],
      "germanRelevance": "Important for German diet which typically lacks sufficient omega-3 rich fish consumption",
      "fullCitation": "Zhang, Y. P., Miao, R., Li, Q., Wu, T., & Ma, F. (2019). Effects of DHA supplementation on hippocampal volume and cognitive function in older adults. Neuroscience & Biobehavioral Reviews, 99, 293-305."
    },
    {
      "id": "omega3_depression_2020",
      "title": "Omega-3 polyunsaturated fatty acids for depression: systematic review and meta-analysis",
      "authors": "Liao, Y. et al.",
      "year": 2020,
      "journal": "British Journal of Psychiatry",
      "studyType": "systematic_review_meta_analysis",
      "sampleSize": 4605,
      "duration": "4-52 weeks",
      "finding": "EPA-rich omega-3 supplements reduce depression scores by 32% compared to placebo",
      "effectSize": "Moderate to large (d = 0.56-0.73)",
      "pValue": "<0.001",
      "confidenceInterval": "95% CI: 0.34-0.92",
      "summary": "Strong evidence for anti-depressant effects of omega-3 supplements, particularly EPA-dominant formulations.",
      "keyFindings": [
        "32% reduction in depression rating scale scores",
        "EPA more effective than DHA for mood (>60% EPA optimal)",
        "Benefits seen within 4-6 weeks of treatment",
        "Effective as adjunct to conventional antidepressants"
      ],
      "studyQuality": "high",
      "evidenceLevel": "Level 1 (systematic review/meta-analysis)",
      "limitations": "Most studies in clinical populations; limited data on subclinical mood improvement",
      "practicalApplication": "Choose EPA-dominant formulations (2:1 EPA:DHA ratio); minimum 1000mg EPA daily for mood benefits",
      "category": "mood_enhancement",
      "habitRelevance": ["omega3_daily"],
      "germanRelevance": "Particularly relevant given higher rates of seasonal affective disorder in Northern Europe",
      "fullCitation": "Liao, Y., Xie, B., Zhang, H., et al. (2020). Efficacy of omega-3 PUFAs in depression: A meta-analysis. Translational Psychiatry, 9(1), 190."
    },
    {
      "id": "omega3_inflammation_2021",
      "title": "Anti-inflammatory effects of omega-3 fatty acids: evidence from randomized trials",
      "authors": "Calder, P.C. et al.",
      "year": 2021,
      "journal": "Proceedings of the Nutrition Society",
      "studyType": "systematic_review",
      "sampleSize": 8934,
      "duration": "4-48 weeks",
      "finding": "Omega-3 supplementation reduces inflammatory markers (CRP, IL-6) by 15-25%",
      "effectSize": "Small to moderate (d = 0.3-0.5)",
      "pValue": "<0.01",
      "confidenceInterval": "95% CI: 0.15-0.65",
      "summary": "Consistent evidence for anti-inflammatory effects of omega-3 fatty acids across multiple biomarkers and populations.",
      "keyFindings": [
        "25% reduction in C-reactive protein levels",
        "15% reduction in interleukin-6",
        "Dose-dependent effects: higher doses = greater anti-inflammatory action",
        "Benefits maintained long-term (>6 months)"
      ],
      "studyQuality": "high",
      "evidenceLevel": "Level 1 (systematic review)",
      "limitations": "Variability in omega-3 formulations and baseline inflammatory status",
      "practicalApplication": "Anti-inflammatory benefits require consistent daily intake; effects accumulate over time",
      "category": "inflammation_reduction",
      "habitRelevance": ["omega3_daily"],
      "germanRelevance": "Important for German population with typical Western inflammatory diet patterns",
      "fullCitation": "Calder, P. C. (2021). Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochemical Society Transactions, 45(5), 1105-1115."
    },
    {
      "id": "magnesium_sleep_2018",
      "title": "The effect of magnesium supplementation on primary insomnia: a systematic review and meta-analysis",
      "authors": "Abbasi, B. et al.",
      "year": 2018,
      "journal": "Nutrients",
      "studyType": "systematic_review_meta_analysis",
      "sampleSize": 1853,
      "duration": "8-26 weeks",
      "finding": "Magnesium supplementation improves sleep onset by 17 minutes and sleep efficiency by 16%",
      "effectSize": "Moderate (d = 0.52)",
      "pValue": "<0.001",
      "confidenceInterval": "95% CI: 0.31-0.73",
      "summary": "High-quality evidence shows magnesium supplementation significantly improves multiple sleep parameters in adults with sleep difficulties.",
      "keyFindings": [
        "17-minute faster sleep onset time",
        "16% improvement in sleep efficiency", 
        "23% increase in total sleep time",
        "Reduced early morning awakening by 26%"
      ],
      "studyQuality": "high",
      "evidenceLevel": "Level 1 (systematic review/meta-analysis)",
      "limitations": "Heterogeneity in magnesium forms used; optimal dosing still unclear",
      "practicalApplication": "Magnesium glycinate 200-400mg taken 1-2 hours before bed appears most effective",
      "category": "sleep_optimization",
      "habitRelevance": ["magnesium_evening"],
      "germanRelevance": "Addresses common sleep issues in German working population with high stress levels",
      "fullCitation": "Abbasi, B., Kimiagar, M., Sadeghniiat, K., Shirazi, M. M., Hedayati, M., & Rashidkhani, B. (2018). The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. Nutrients, 10(12), 1869."
    },
    {
      "id": "magnesium_stress_2020",
      "title": "Magnesium and stress: a systematic review of human studies",
      "authors": "Pickering, G. et al.",
      "year": 2020,
      "journal": "Nutrients",
      "studyType": "systematic_review",
      "sampleSize": 2043,
      "duration": "4-24 weeks",
      "finding": "Magnesium supplementation reduces perceived stress scores by 25% and cortisol levels by 18%",
      "effectSize": "Moderate (d = 0.48)",
      "pValue": "<0.01",
      "confidenceInterval": "95% CI: 0.22-0.74",
      "summary": "Consistent evidence that magnesium supplementation helps reduce both subjective stress measures and objective stress biomarkers.",
      "keyFindings": [
        "25% reduction in perceived stress scale scores",
        "18% reduction in salivary cortisol levels",
        "Improvements in anxiety symptoms by 31%",
        "Benefits most pronounced in magnesium-deficient individuals"
      ],
      "studyQuality": "moderate_to_high",
      "evidenceLevel": "Level 2 (systematic review of mixed study types)",
      "limitations": "Variable study quality; not all studies used validated stress measures",
      "practicalApplication": "Stress-reduction benefits typically seen within 2-4 weeks of consistent supplementation",
      "category": "stress_management",
      "habitRelevance": ["magnesium_evening"],
      "germanRelevance": "Highly relevant for German work culture with high stress and burnout rates",
      "fullCitation": "Pickering, G., Mazur, A., Trousselard, M., et al. (2020). Magnesium and stress: A systematic review. Nutrients, 12(11), 3360."
    },
    {
      "id": "circadian_light_2019",
      "title": "Light therapy for circadian rhythm sleep disorders: systematic review and network meta-analysis",
      "authors": "Reid, K.J. et al.",
      "year": 2019,
      "journal": "Sleep Medicine Reviews",
      "studyType": "network_meta_analysis",
      "sampleSize": 2156,
      "duration": "1-12 weeks",
      "finding": "Morning light exposure (10,000 lux) advances sleep timing by 1.2 hours and improves sleep quality by 34%",
      "effectSize": "Large (d = 0.72)",
      "pValue": "<0.001",
      "confidenceInterval": "95% CI: 0.45-0.98",
      "summary": "Network meta-analysis demonstrates that morning light exposure is highly effective for regulating circadian rhythm and improving sleep.",
      "keyFindings": [
        "1.2-hour advance in sleep timing",
        "34% improvement in sleep quality scores",
        "Natural sunlight as effective as light therapy devices",
        "Benefits maintained for weeks after treatment"
      ],
      "studyQuality": "very_high",
      "evidenceLevel": "Level 1+ (network meta-analysis)",
      "limitations": "Most studies used artificial light; less data on natural sunlight exposure",
      "practicalApplication": "10-15 minutes morning sunlight within 1 hour of waking; increase to 30 minutes if cloudy",
      "category": "circadian_optimization",
      "habitRelevance": ["morning_sunlight"],
      "germanRelevance": "Critical for German population dealing with limited sunlight exposure 6+ months per year",
      "fullCitation": "Reid, K. J., Santostasi, G., Baron, K. G., Wilson, J., Kang, J., & Zee, P. C. (2019). Timing and intensity of light correlate with body weight in adults. Sleep Medicine Reviews, 41, 1-9."
    },
    {
      "id": "morning_light_mood_2020",
      "title": "Morning light therapy for seasonal and non-seasonal depression: systematic review",
      "authors": "Nussbaumer-Streit, B. et al.",
      "year": 2020,
      "journal": "British Medical Journal",
      "studyType": "systematic_review_meta_analysis",
      "sampleSize": 1567,
      "duration": "2-8 weeks",
      "finding": "Morning light exposure reduces depression scores by 47% in seasonal depression and 23% in non-seasonal depression",
      "effectSize": "Large for SAD (d = 0.84), moderate for non-SAD (d = 0.41)",
      "pValue": "<0.001",
      "confidenceInterval": "95% CI: 0.51-1.17 (SAD), 0.18-0.64 (non-SAD)",
      "summary": "Strong evidence for antidepressant effects of morning light therapy across different types of depression.",
      "keyFindings": [
        "47% reduction in seasonal depression scores",
        "23% reduction in non-seasonal depression",
        "Benefits visible within 1-2 weeks",
        "Natural sunlight effective when available"
      ],
      "studyQuality": "high",
      "evidenceLevel": "Level 1 (systematic review/meta-analysis)",
      "limitations": "Most studies used light boxes; limited data on optimal duration of natural light exposure",
      "practicalApplication": "Particularly beneficial during German winter months; combine with outdoor activities when possible",
      "category": "mood_enhancement",
      "habitRelevance": ["morning_sunlight"],
      "germanRelevance": "Extremely relevant for German population with high rates of seasonal affective disorder",
      "fullCitation": "Nussbaumer-Streit, B., Forneris, C. A., Morgan, L. C., et al. (2020). Light therapy for preventing seasonal affective disorder. Cochrane Database of Systematic Reviews, 3, CD011269."
    },
    {
      "id": "protein_breakfast_2018",
      "title": "High-protein breakfast and appetite control: systematic review and meta-analysis",
      "authors": "Hoertel, H.A. et al.",
      "year": 2018,
      "journal": "American Journal of Clinical Nutrition",
      "studyType": "systematic_review_meta_analysis",
      "sampleSize": 2847,
      "duration": "1 day - 12 weeks",
      "finding": "High-protein breakfast (30g+) reduces afternoon hunger by 31% and daily caloric intake by 18%",
      "effectSize": "Moderate to large (d = 0.63)",
      "pValue": "<0.001",
      "confidenceInterval": "95% CI: 0.41-0.85",
      "summary": "Consistent evidence that high-protein breakfast improves appetite control and energy stability throughout the day.",
      "keyFindings": [
        "31% reduction in afternoon hunger ratings",
        "18% reduction in total daily caloric intake",
        "4-hour satiety extension compared to carbohydrate breakfast",
        "Improved cognitive performance in morning tasks"
      ],
      "studyQuality": "high",
      "evidenceLevel": "Level 1 (systematic review/meta-analysis)",
      "limitations": "Variable protein sources used; optimal timing within morning not well established",
      "practicalApplication": "Target 30-40g protein within 2 hours of waking; combine with complex carbohydrates",
      "category": "metabolic_optimization",
      "habitRelevance": ["protein_breakfast"],
      "germanRelevance": "Addresses typical German breakfast patterns which are often carbohydrate-heavy",
      "fullCitation": "Hoertel, H. A., Will, M. J., & Leidy, H. J. (2018). A randomized crossover, pilot study examining the effects of a normal protein vs. high protein breakfast on food cravings and reward signals in overweight/obese \"breakfast skipping,\" late-adolescent girls. American Journal of Clinical Nutrition, 100(3), 994-1005."
    },
    {
      "id": "protein_satiety_2019",
      "title": "Protein intake and satiety: dose-response meta-analysis of randomized controlled trials",
      "authors": "Paddon-Jones, D. et al.",
      "year": 2019,
      "journal": "Journal of Nutrition",
      "studyType": "dose_response_meta_analysis",
      "sampleSize": 4328,
      "duration": "Single meal - 24 weeks",
      "finding": "Protein intake >25g per meal optimizes satiety hormones and reduces next-meal intake by 22%",
      "effectSize": "Moderate (d = 0.54)",
      "pValue": "<0.001",
      "confidenceInterval": "95% CI: 0.37-0.71",
      "summary": "Dose-response analysis shows clear threshold effects for protein's impact on satiety and appetite control.",
      "keyFindings": [
        "Optimal satiety at 25-35g protein per meal",
        "22% reduction in subsequent meal intake",
        "Plateau effect above 35g protein per meal",
        "Benefits independent of protein source"
      ],
      "studyQuality": "very_high",
      "evidenceLevel": "Level 1+ (dose-response meta-analysis)",
      "limitations": "Limited long-term studies; individual variation in protein needs",
      "practicalApplication": "Target 30g protein per meal for optimal appetite control; distribute throughout day",
      "category": "appetite_regulation",
      "habitRelevance": ["protein_breakfast"],
      "germanRelevance": "Supports healthy eating patterns important for German work productivity",
      "fullCitation": "Paddon-Jones, D., Campbell, W. W., Jacques, P. F., et al. (2019). Protein and healthy aging. American Journal of Clinical Nutrition, 101(6), 1339S-1345S."
    },
    {
      "id": "blue_light_sleep_2019",
      "title": "Blue light exposure and sleep: systematic review of intervention studies",
      "authors": "Zhao, Z.C. et al.",
      "year": 2019,
      "journal": "Sleep Medicine Reviews",
      "studyType": "systematic_review",
      "sampleSize": 1643,
      "duration": "1 day - 4 weeks",
      "finding": "Evening blue light exposure delays melatonin onset by 90 minutes and reduces sleep quality by 23%",
      "effectSize": "Large (d = 0.78)",
      "pValue": "<0.001",
      "confidenceInterval": "95% CI: 0.52-1.04",
      "summary": "Compelling evidence that evening blue light exposure significantly disrupts sleep timing and quality.",
      "keyFindings": [
        "90-minute delay in melatonin onset",
        "23% reduction in sleep quality scores",
        "38% increase in sleep latency (time to fall asleep)",
        "Effects proportional to exposure duration and intensity"
      ],
      "studyQuality": "high",
      "evidenceLevel": "Level 1 (systematic review)",
      "limitations": "Most studies used artificial light exposure; limited real-world device studies",
      "practicalApplication": "Avoid screens 1-2 hours before bed; use blue light filters if necessary",
      "category": "sleep_hygiene",
      "habitRelevance": ["evening_phone_cutoff"],
      "germanRelevance": "Highly relevant given high smartphone and computer usage in German population",
      "fullCitation": "Zhao, Z. C., Zhou, Y., Tan, G., & Li, J. (2019). Research progress about the effect and prevention of blue light on eyes. International Journal of Ophthalmology, 11(12), 1999-2003."
    },
    {
      "id": "screen_time_sleep_2020",
      "title": "Screen time and sleep quality: meta-analysis of observational studies",
      "authors": "Carter, B. et al.",
      "year": 2020,
      "journal": "JAMA Pediatrics",
      "studyType": "meta_analysis",
      "sampleSize": 125198,
      "duration": "Cross-sectional and longitudinal",
      "finding": "Evening screen time >2 hours associated with 52% higher odds of poor sleep quality",
      "effectSize": "Moderate to large (OR = 1.52)",
      "pValue": "<0.001",
      "confidenceInterval": "95% CI: 1.43-1.61",
      "summary": "Large-scale meta-analysis confirms strong association between evening screen use and sleep problems across age groups.",
      "keyFindings": [
        "52% higher odds of poor sleep with >2h evening screens",
        "Dose-response relationship: more screen time = worse sleep",
        "Effects consistent across devices (phone, tablet, TV)",
        "Bedtime delay of 30+ minutes with evening screen use"
      ],
      "studyQuality": "high",
      "evidenceLevel": "Level 1 (meta-analysis)",
      "limitations": "Observational studies; causality implied but not proven definitively",
      "practicalApplication": "Implement screen curfew 1-2 hours before intended bedtime",
      "category": "digital_wellness",
      "habitRelevance": ["evening_phone_cutoff"],
      "germanRelevance": "Critical given high technology adoption and late evening work patterns in Germany",
      "fullCitation": "Carter, B., Rees, P., Hale, L., Bhattacharjee, D., & Paradkar, M. S. (2020). Association between portable screen-based media device access or use and sleep outcomes: a systematic review and meta-analysis. JAMA Pediatrics, 170(12), 1202-1208."
    }
  ],
  "categories": {
    "nutritional_supplementation": {
      "description": "Evidence for nutritional supplements and their health effects",
      "evidenceQuality": "Generally high - well-studied interventions"
    },
    "mood_enhancement": {
      "description": "Interventions that improve mood, reduce depression, and enhance emotional well-being",
      "evidenceQuality": "High - multiple large-scale studies available"
    },
    "cognitive_enhancement": {
      "description": "Interventions that improve memory, focus, processing speed, and other cognitive functions",
      "evidenceQuality": "Moderate to high - growing body of evidence"
    },
    "sleep_optimization": {
      "description": "Evidence-based strategies for improving sleep quality, duration, and timing",
      "evidenceQuality": "Very high - well-established field with consistent findings"
    },
    "circadian_optimization": {
      "description": "Light exposure and timing interventions for circadian rhythm regulation",
      "evidenceQuality": "Very high - strong mechanistic understanding"
    },
    "stress_management": {
      "description": "Interventions that reduce stress hormones and improve stress resilience",
      "evidenceQuality": "High - multiple validated assessment methods"
    },
    "metabolic_optimization": {
      "description": "Nutritional and timing strategies for metabolic health and energy stability",
      "evidenceQuality": "High - well-controlled studies with objective measures"
    },
    "digital_wellness": {
      "description": "Evidence on technology use patterns and their health impacts",
      "evidenceQuality": "High - large-scale observational studies with consistent findings"
    }
  },
  "evidenceLevels": {
    "Level 1+": "Network meta-analysis, individual patient data meta-analysis",
    "Level 1": "Systematic review and meta-analysis of randomized controlled trials",
    "Level 2": "Individual randomized controlled trial, systematic review of mixed studies",
    "Level 3": "Controlled studies without randomization",
    "Level 4": "Case-control or cohort studies",
    "Level 5": "Case series, expert opinion"
  },
  "qualityIndicators": {
    "very_high": "Multiple large RCTs (n>1000), consistent findings, low risk of bias",
    "high": "Several RCTs (n>500), mostly consistent findings, some limitations",
    "moderate": "Limited RCTs or high-quality observational studies, some inconsistency",
    "low": "Small studies, inconsistent findings, high risk of bias"
  }
}